ENTITY
Shanghai Henlius Biotech

Shanghai Henlius Biotech (2696 HK)

317
Analysis
Health CareChina
Shanghai Henlius Biotech, Inc develops and produces drugs. The Company develops and produces monoclonal antibody biosimilar drugs, bio betters, novel monoclonal antibodys, and other drugs. Shanghai Henlius Biotech throughout China.
more
bullishFuji Soft Inc
28 Sep 2024 15:00

(Mostly) Asia-Pac M&A: Dyna Mac, Platinum Asset, Fuji Soft, JTower, Arvida, Korea Zinc, Sun Art

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
523 Views
Share
23 Sep 2024 00:18

Merger Arb Mondays (23 Sep) - Henlius, GA Pack, China TCM, Canvest, Trancom, Fuji Soft, Platinum

This week, the highest gross spreads are Canvest (8.6%), Shinko Electric (7.2%), GA Pack (6.9%), Henlius (6.7%), China TCM (5.7%), Capitol Health...

Logo
540 Views
Share
16 Sep 2024 00:41

Merger Arb Mondays (16 Sep) - China TCM, Canvest, GA Pack, Raysum, Seven & I, Fuji Soft, Dyna-Mac

This week, the highest gross spreads are HEC Pharma (139.1%), Raysum (94.2%), Canvest (8.4%), GAPack (7.3%), China TCM (6.5%), Henlius (6.3%),...

Logo
674 Views
Share
10 Sep 2024 08:55

Shanghai Henlius Biotech (2696.HK) Privatization Update - Some New Information Worth the Attention

Fosun Pharma will make every effort to promote the success of privatization due to plans for Henlius internal integration with Fosun Pharma and...

Logo
699 Views
Share
09 Sep 2024 00:39

Merger Arb Mondays (09 Sep) - Shinko, Fuji Soft, Pasco, GA Pack, CPMC, Latin Res, Capitol, PSC, Rex

This week, the highest gross spreads are HEC Pharma (116.0%), Canvest (8.4%), Shinko Electric (7.9%), Malaysia Airports (7.4%), GA Pack (6.9%),...

Logo
544 Views
Share
x